Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


1 BMC Cancer
1 Cancer
2 Gynecol Oncol
2 Hum Pathol
1 Int J Gynaecol Obstet
3 Int J Oncol
2 Oncol Rep
4 PLoS One
1 Tumour Biol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Cancer

  1. SMOGELI E, Davidson B, Cvancarova M, Holth A, et al
    L1CAM as a prognostic marker in stage I endometrial cancer: a validation study.
    BMC Cancer. 2016;16:596.
    PubMed     Text format     Abstract available


  2. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    PubMed     Text format    

    Gynecol Oncol

  3. DOCKERY LE, Tew WP, Ding K, Moore KN, et al
    Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer.
    Gynecol Oncol. 2017 Oct 13. pii: S0090-8258(17)31364.
    PubMed     Text format     Abstract available

  4. POZZAR RA, Berry DL
    Patient-centered research priorities in ovarian cancer: A systematic review of potential determinants of guideline care.
    Gynecol Oncol. 2017 Oct 10. pii: S0090-8258(17)31365.
    PubMed     Text format     Abstract available

    Hum Pathol

  5. RUSSO M, Broach J, Sheldon K, Houser KR, et al
    Clonal Evolution in Paired Endometrial Intraepithelial Neoplasia/Atypical Hyperplasia and Endometrioid Adenocarcinoma.
    Hum Pathol. 2017 Jul 13. pii: S0046-8177(17)30244.
    PubMed     Text format     Abstract available

  6. TAUBE ET, Denkert C, Sehouli J, Unger U, et al
    Cytokeratin 5/6 expression, prognosis and association with ER-alpha in high-grade serous ovarian carcinoma.
    Hum Pathol. 2017 Apr 13. pii: S0046-8177(17)30105.
    PubMed     Text format     Abstract available

    Int J Gynaecol Obstet

  7. ZHANG T, Li F, Liu J, Zhang S, et al
    Diagnostic performance of the Gynecology Imaging Reporting and Data System for malignant adnexal masses.
    Int J Gynaecol Obstet. 2017 Mar 13. doi: 10.1002/ijgo.12153.
    PubMed     Text format     Abstract available

    Int J Oncol

  8. SHETA R, Bachvarova M, Plante M, Gregoire J, et al
    Altered expression of different GalNActransferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
    Int J Oncol. 2017 Oct 9. doi: 10.3892/ijo.2017.4147.
    PubMed     Text format     Abstract available

  9. BU S, Zhang Q, Wang Q, Lai D, et al
    Human amniotic epithelial cells inhibit growth of epithelial ovarian cancer cells via TGFbeta1-mediated cell cycle arrest.
    Int J Oncol. 2017 Sep 14. doi: 10.3892/ijo.2017.4123.
    PubMed     Text format     Abstract available

  10. PAN H, Wang F, Rankin GO, Rojanasakul Y, et al
    Inhibitory effect of black tea pigments, theaflavin3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.
    Int J Oncol. 2017 Oct 3. doi: 10.3892/ijo.2017.4145.
    PubMed     Text format     Abstract available

    Oncol Rep

  11. SU F, Geng J, Li X, Qiao C, et al
    SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumabresistant ovarian cancer model.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5998.
    PubMed     Text format     Abstract available

  12. XIE X, Yang M, Ding Y, Yu L, et al
    Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
    Oncol Rep. 2017 Oct 13. doi: 10.3892/or.2017.6034.
    PubMed     Text format     Abstract available

    PLoS One

  13. HARTER P, Hauke J, Heitz F, Reuss A, et al
    Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
    PLoS One. 2017;12:e0186043.
    PubMed     Text format     Abstract available

  14. GUO Z, Wang X, Cheng D, Xia Z, et al
    Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer.
    PLoS One. 2017;12:e0186965.
    PubMed     Text format     Abstract available

  15. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    PubMed     Text format     Abstract available

  16. FORNARO L, Vivaldi C, Lin D, Xue H, et al
    Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.
    PLoS One. 2017;12:e0182818.
    PubMed     Text format     Abstract available

    Tumour Biol

  17. SADLECKI P, Antosik P, Grzanka D, Grabiec M, et al
    KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.
    Tumour Biol. 2017;39:1010428317733984.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.